ACTT Trial Results Indicate Remdesivir’s Efficacy Against Covid-19 The National Institutes of Health released interim #data from the Phase 3 ACTT trial, which explores #remdesivir for […]

#Takeda has added a #Covid19 Expansion arm to their phase 1 trial exploring the small molecule TAK-981 in solid tumors and hematologic malignancies. As this #pandemic […]

#Kognitic has made it our mission to make #Covid19 clinical research publicly accessible. True accessibility not only requires data, but the knowledge necessary to interpret that […]

#Kognitic has made it our mission to make #Covid19 clinical research publicly accessible. True accessibility not only requires data, but the knowledge necessary to interpret that […]

The COVID-19 WORLDWIDE CLINICAL DEVELOPMENT Dashboard, powered by #Kognitic, is an integrated tool which places the power to deep-dive into #Covid19data in the hands of the […]

Today, #Kognitic released our #Covid_19 dashboard which leverages #machinelearning to capture data from Covid-19 #clinicaltrials in real-time. This portal integrates industry data to provide high-level insights […]

Today, #Kognitic opens public access to our insight-driven, live dashboard to keep abreast of all the #Covid19 clinical developments! Updated daily with data sourced directly from […]

Behind-the-Scenes Heroes of COVID-19 #Kognitic would like to take a moment to thank the #researchers who are working unremittingly to find a #cure for #covid19. These […]

Kognitic announces the launch of an innovative feature to its platform, one which allows its customers to plot the geographic location of active clinical trials into […]